EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1

Jianyong Deng, Xuan Yi, Zuxi Feng, Jie Peng, Dan Li, Chen Li, Binbin Deng, Shuaigang Liu, Souradeep Sahu, Liang Hao iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jianyong Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma (OS) is a fatal adolescent tumor, which is susceptible to remote metastases at an early stage, and its treatment remains a major challenge. ubiquitin‐specific protease 10 (USP10) is primarily located in the cytoplasm and can therefore deubiquitinate various cytoplasmic proteins. However, the expression and mechanism of USP10 in OS remain ambiguous. The aim of this study was to explore how USP10 affects Yes‐associated protein1 (YAP1) to influence the metastasis and epithelial–mesenchymal transition (EMT).

Methods

Western blotting, qRT‐PCR, and immunohistochemical (IHC) analyses were performed to evaluate USP10 and YAP1 levels. Using wound healing and transwell tests, the roles and molecular pathways of USP10 and YAP1 ability to migrate and invade of OS were investigated, and cell morphological alterations were examined using phalloidin staining.

Results

Our results indicated that USP10, a new type of deubiquitinating protease, is increased in OS tissues and cells contrasted with adjacent healthy tissues. Overexpression of USP10 correlated with tumor size, distant metastasis, and TNM stage, and was an independent factor of poor prognosis in OS patients. Also, USP10 expression is closely connected with the incident of OS metastasis and tumor size. Functional assays revealed that USP10 knockdown suppressed cell migrating and invading ability and inhibited the EMT of OS cells in vivo and in vitro. In addition, we showed that USP10 knockdown decreased the levels of YAP1, which is an important positive regulator of migration and invasion in many cancers. We also found a significant positive correlation between USP10 and YAP1 levels, further demonstrating that USP10‐induced migration and EMT are based on YAP1 in OS cells. In a mechanistic way, USP10 stabilizes the expression of YAP1 by mediating its deubiquitination in OS cells.

Conclusion

Together, this study showed that USP10 can directly interact with YAP1 to reduce ubiquitinated YAP1, thereby stabilizing its protein levels and affecting EMT and distant metastasis in OS cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaAdolescentHumansCell Line, TumorCell MovementCell ProliferationDeubiquitinating EnzymesEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticUbiquitin ThiolesteraseYAP-Signaling Proteins

Stichwörter der Autor:innen

EMTUSP10YAP1deubiquitinationosteosarcoma

Substanzen

Deubiquitinating EnzymesUbiquitin ThiolesteraseUSP10 protein, humanYAP1 protein, humanYAP-Signaling Proteins

Autor:innen und Institutionen

  • Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.

ORCID-Profile: Liang Hao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, J., Yi, X., Feng, Z., Peng, J., Li, D., Li, C., Deng, B., Liu, S., Sahu, S., & Hao, L. (2023). Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1. Cancer Medicine. https://doi.org/10.1002/cam4.6074

Vancouver

Deng J, Yi X, Feng Z, Peng J, Li D, Li C, et al. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1. Cancer Medicine. 2023. doi:10.1002/cam4.6074

BibTeX
@article{Deng2023,
  author = {Deng, Jianyong and Yi, Xuan and Feng, Zuxi and Peng, Jie and Li, Dan and Li, Chen and Deng, Binbin and Liu, Shuaigang and Sahu, Souradeep and Hao, Liang},
  title = {Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6074}
}
Kostenlos starten →